Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.

Literature DB >> 24493471

Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.

Abstract

There is a dearth of epidemiological data about multiple sclerosis (MS) and related demyelinating disorders in India. In this study, a registry method was used for collecting data from secure sources and the index cases were verified Seventy nine patients were identified . A crude prevalence of 8.3/100,000 was obtained for MS and 6.2/100,000 for clinically-isolated syndrome (CIS). Age-standardized prevalence of MS relative to the world population was 7.8/100,000. Neuromyelitis optica (NMO) and spectrum disorders (NMOS) constituted 13.9% of all demyelinating disorders, with a prevalence of 2.6/100,000. Larger studies with more refined survey methodologies are required to understand the true prevalence of demyelinating disorders in India.

Entities: Disease Species

Keywords: Clinically isolated syndrome; India; demyelinating disorders; epidemiology; multiple sclerosis; neuromyelitis optica; prevalence; registry

Mesh：

Year: 2014 PMID： 24493471 DOI： 10.1177/1352458514521503

Source DB: PubMed Journal: Mult Scler ISSN： 1352-4585 Impact factor: 6.312

Keyword Cloud
Cited

24 in total

1. Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta.

Authors: Sara Salama; Hazem Marouf; M Ihab Reda; Amal R Mansour; Osama ELKholy; Michael Levy
Journal: J Neuroimmunol Date: 2018-08-29 Impact factor: 3.478

2. The clinical profile of NMOSD in Australia and New Zealand.

Authors: Wajih Bukhari; Laura Clarke; Cullen O'Gorman; Elham Khalilidehkordi; Simon Arnett; Kerri M Prain; Mark Woodhall; Roger Silvestrini; Christine S Bundell; Sudarshini Ramanathan; David Abernethy; Sandeep Bhuta; Stefan Blum; Mike Boggild; Karyn Boundy; Bruce J Brew; Wallace Brownlee; Helmut Butzkueven; William M Carroll; Celia Chen; Alan Coulthard; Russell C Dale; Chandi Das; Keith Dear; Marzena J Fabis-Pedrini; David Fulcher; David Gillis; Simon Hawke; Robert Heard; Andrew P D Henderson; Saman Heshmat; Suzanne Hodgkinson; Sofia Jimenez-Sanchez; Trevor J Kilpatrick; John King; Chris Kneebone; Andrew J Kornberg; Jeannette Lechner-Scott; Ming-Wei Lin; Christopher Lynch; Richard A L Macdonnell; Deborah F Mason; Pamela A McCombe; Jennifer Pereira; John D Pollard; Stephen W Reddel; Cameron Shaw; Judith Spies; James Stankovich; Ian Sutton; Steve Vucic; Michael Walsh; Richard C Wong; Eppie M Yiu; Michael H Barnett; Allan G Kermode; Mark P Marriott; John Parratt; Mark Slee; Bruce V Taylor; Ernest Willoughby; Robert J Wilson; Fabienne Brilot; Angela Vincent; Patrick Waters; Simon A Broadley
Journal: J Neurol Date: 2020-01-31 Impact factor: 4.849

3. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Authors: Eoin P Flanagan; Philippe Cabre; Brian G Weinshenker; Jennifer St Sauver; Debra J Jacobson; Masoud Majed; Vanda A Lennon; Claudia F Lucchinetti; Andrew McKeon; Marcelo Matiello; Nilifur Kale; Dean M Wingerchuk; Jay Mandrekar; Jessica A Sagen; James P Fryer; Angala Borders Robinson; Sean J Pittock
Journal: Ann Neurol Date: 2016-04-04 Impact factor: 10.422

10. Patient-reported outcome measure for neuromyelitis optica: pretesting of preliminary instrument and protocol for further development in accordance with international guidelines.

Authors: P Moore; C Jackson; K Mutch; A Methley; C Pollard; S Hamid; A Jacob
Journal: BMJ Open Date: 2016-09-30 Impact factor: 2.692

Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.

1. Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta.

2. The clinical profile of NMOSD in Australia and New Zealand.

3. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Review 4. Demographic and clinical features of neuromyelitis optica: A review.

Review 5. Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis.

6. Environmental factors related to multiple sclerosis in Indian population.

7. Profile of neuromyelitis optica and spectrum disorders in an Indian cohort.

Review 8. Neuromyelitis optica spectrum disorders: An update.

Review 9. Multiple sclerosis in India: An overview.

10. Patient-reported outcome measure for neuromyelitis optica: pretesting of preliminary instrument and protocol for further development in accordance with international guidelines.